Colm J. O’Rourke

1.8k total citations
34 papers, 560 citations indexed

About

Colm J. O’Rourke is a scholar working on Surgery, Cancer Research and Molecular Biology. According to data from OpenAlex, Colm J. O’Rourke has authored 34 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 16 papers in Cancer Research and 12 papers in Molecular Biology. Recurrent topics in Colm J. O’Rourke's work include Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers), RNA modifications and cancer (8 papers) and Epigenetics and DNA Methylation (7 papers). Colm J. O’Rourke is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers), RNA modifications and cancer (8 papers) and Epigenetics and DNA Methylation (7 papers). Colm J. O’Rourke collaborates with scholars based in Denmark, United States and Ireland. Colm J. O’Rourke's co-authors include Jesper B. Andersen, Patricia Muñoz-Garrido, Douglas V.N.P. Oliveira, A Taranta, Chirag Nepal, Xin Wei Wang, Jesús M. Bañales, Lewis R. Roberts, Prson Gautam and Chiara Raggi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Gut.

In The Last Decade

Colm J. O’Rourke

31 papers receiving 558 citations

Peers

Countries citing papers authored by Colm J. O’Rourke

Since Specialization

Citations

This map shows the geographic impact of Colm J. O’Rourke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colm J. O’Rourke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colm J. O’Rourke more than expected).

Fields of papers citing papers by Colm J. O’Rourke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colm J. O’Rourke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colm J. O’Rourke. The network helps show where Colm J. O’Rourke may publish in the future.

Co-authorship network of co-authors of Colm J. O’Rourke

This figure shows the co-authorship network connecting the top 25 collaborators of Colm J. O’Rourke. A scholar is included among the top collaborators of Colm J. O’Rourke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colm J. O’Rourke. Colm J. O’Rourke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Personalized Neoadjuvant Chemotherapy for Gastrointestinal Cancers: Shaping Imprecision to be Precise 2025 ·Clinical Cancer Research ·(unknown), Jakob Vasehus Schou, (unknown), Jesper B. Andersen, Colm J. O’Rourke	0
2	Clinical, radiological, and molecular insights into extracranial metastases from adult gliomas 2025 ·Neuro-Oncology ·(unknown), (unknown), Colm J. O’Rourke, Jonathan Frederik Carlsen, Jonathan Cohen, Jonathan A. Ewald, David Scheie, Kirsten Grunnet, Alexander Schmidt, Linea Cecilie Melchior, Vibeke A. Larsen, Jesper B. Andersen, Hans Skovgaard Poulsen, Joachim Weischenfeldt, Helle Broholm, Signe Regner Michaelsen, Bjarne Winther Kristensen	0
3	Validation of Two Prognostic Gene Scores in Patients Undergoing Liver Resection for Hepatocellular Carcinoma 2025 ·Journal of Clinical and Experimental Hepatology ·Saskia Maria Schnabl, (unknown), Colm J. O’Rourke, (unknown), Jan‐Michael Kugler, Susanne Dam Nielsen, Jesper B. Andersen, Hans‐Christian Pommergaard	1
4	Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma 2024 ·Gut ·Ekaterina Zhuravleva, Monika Lewińska, Colm J. O’Rourke, Antonio Pea, (unknown), Ann W. Hsing, A Taranta, David K. Chang, Yu-Tang Gao, Jill Koshiol, Rui Caetano Oliveira, Jesper B. Andersen	1
5	Developing a DNA Methylation Signature to Differentiate High-Grade Serous Ovarian Carcinomas from Benign Ovarian Tumors 2024 ·Molecular Diagnosis & Therapy ·Douglas V.N.P. Oliveira, Edyta Biskup, Colm J. O’Rourke, Julie L. Hentze, Jesper B. Andersen, Claus Høgdall, Estrid Høgdall	1
6	Targeted therapies in biliary tract cancer—when precision becomes imprecise 2024 ·SHILAP Revista de lepidopterología ·Colm J. O’Rourke, Jakob Vasehus Schou, Jesper B. Andersen, (unknown)	1
7	miR‐21‐5p promotes NASH‐related hepatocarcinogenesis 2023 ·Liver International ·Pedro M. Rodrigues, Marta B. Afonso, André L. Simão, Tawhidul Islam, Maria Manuela Gaspar, Colm J. O’Rourke, Monika Lewińska, Jesper B. Andersen, Enara Arretxe, Cristina Alonso, Álvaro Santos‐Laso, Laura Izquierdo‐Sánchez, Raúl Jiménez-Agüero, (unknown), Luís Bujanda, María Jesús Pareja, Carina Prip‐Buus, Jesús M. Bañales, Cecília M. P. Rodrigues, Rui E. Castro	22
8	Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancer 2023 ·Frontiers in Oncology ·(unknown), Martin Cornillet, Dan Sun, Iva Filipovic, Christian Sturesson, Colm J. O’Rourke, Jesper B. Andersen, Niklas K. Björkström, Ernesto Sparrelid	4
9	Immunogenomics of cholangiocarcinoma 2023 ·Hepatology ·(unknown), Colm J. O’Rourke, Jesper B. Andersen	1
10	MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells 2022 ·Journal of Hepatology ·(unknown), Patricia Muñoz-Garrido, Monika Lewińska, (unknown), Letizia Satriano, (unknown), A Taranta, Boye Schnack Nielsen, Awaisa Ghazal, Matthias S. Matter, Jesús M. Bañales, Blanca I. Aldana, Yu‐Tang Gao, Jens U. Marquardt, Lewis R. Roberts, Rui Caetano Oliveira, Jill Koshiol, Colm J. O’Rourke, Jesper B. Andersen	21
11	Molecular therapeutic targets for cholangiocarcinoma: Present challenges and future possibilities 2022 ·Advances in cancer research ·(unknown), Colm J. O’Rourke, Jesper B. Andersen	2
12	Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer 2022 ·Journal of Hepatology ·(unknown), Colm J. O’Rourke, Finn Ole Larsen, (unknown), (unknown), Awaisa Ghazal, Mogens K. Boisen, Patricia Muñoz-Garrido, Julia S. Johansen, Jesper B. Andersen	16
13	Mucosal‐associated invariant T‐cell tumor infiltration predicts long‐term survival in cholangiocarcinoma 2021 ·Hepatology ·Christine L. Zimmer, Iva Filipovic, Martin Cornillet, Colm J. O’Rourke, Lena Berglin, (unknown), Dan Sun, Otto Strauß, Laura Hertwig, H Johansson, Erik von Seth, Ernesto Sparrelid, Joana Dias, Hans Glaumann, Espen Melum, Ewa Ellis, Johan K. Sandberg, Jesper B. Andersen, Annika Bergquist, Niklas K. Björkström	26
14	Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer 2021 ·Clinical Epigenetics ·(unknown), Bruce Moran, Anne‐Marie Baird, Colm J. O’Rourke, Stephen P. Finn, Ray McDermott, William Watson, William M. Gallagher, Donal J. Brennan, Antoinette S. Perry	19
15	Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis 2021 ·JCI Insight ·Carolin Czauderna, Alicia Poplawski, Colm J. O’Rourke, Darko Castven, (unknown), Diana Becker, Stefanie Heilmann‐Heimbach, Margarete Odenthal, (unknown), (unknown), Uta Drebber, Harald Binder, Dirk A. Ridder, Mario Schindeldecker, Beate K. Straub, Peter R. Galle, Jesper B. Andersen, Snorri S. Thorgeirsson, Young Nyun Park, Jens U. Marquardt	15
16	Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers 2020 ·Clinical Cancer Research ·(unknown), Colm J. O’Rourke, Christian Dehlendorff, Ole Larsen, Lars Henrik Jensen, Astrid Z. Johansen, Hien Dang, Valentina M. Factor, Mie Grunnet, Morten Mau‐Sørensen, Douglas V.N.P. Oliveira, Dorte Linnemann, Mogens K. Boisen, Xin Wei Wang, Julia S. Johansen, Jesper B. Andersen	21
17	Molecular Targets in Cholangiocarcinoma 2020 ·Hepatology ·Colm J. O’Rourke, Patricia Muñoz-Garrido, Jesper B. Andersen	31
18	Epigenome dysregulation in cholangiocarcinoma 2017 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Colm J. O’Rourke, Patricia Muñoz-Garrido, (unknown), Jesper B. Andersen	37
19	Molecular Pathogenesis and Current Therapy in Intrahepatic Cholangiocarcinoma 2016 ·Digestive Diseases ·(unknown), Colm J. O’Rourke, A Taranta, Douglas V.N.P. Oliveira, Jesper B. Andersen	19
20	Mining methylome databases 2012 ·Trends in Genetics ·Colm J. O’Rourke, Therese M. Murphy, Donal Hollywood, Antoinette S. Perry	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact